DexCom, Inc. (NasdaqGS:DXCM) is looking for M&A. Jereme Sylvain, Executive Vice President and Chief Financial Officer, "that's not the only area we're focused, we're also focused on areas around capital deployment and value creation opportunities. We're certainly positioning the business to maximize it. Our capital deployment priorities, we are investing where the ROI is there.

And when it's not there, there's plenty of room there. But our run rate CapEx is around $200 million to $300 million. So you'll find when we get back to normal CapEx investment, that free cash flow continues to drive even further.

We use that cash flow to look for opportunistic M&A, share buybacks, addressing dilution associated with our debt and also funding future organic growth".